News

The positive results from REV technology have induced the pharma company to actively participate in the testing program, which aims to refine the processes and seek FDA approval

The implementation includes Revitas CARS, CARS BI, Medicaid Rebates and Government Pricing solutions. Glenmark executive vice president Paul Dutra said the Flex platform is an end-to-end automated solution

Omkar Speciality Chemicals chairman and managing director Pravin Herlekar was quoted by business-standard as saying that though some high-end molecules are ready for commercialization, the company is facing

The partnership will focus on developing self-injectable treprostinil molecule, the active ingredient in Remodulin (treprostinil) injection, for pulmonary arterial hypertension (PAH). The TransCon technology platform is expected enhance

Under the collaboration, GNS will use its supercomputer-driven Reverse Engineering and Forward Simulation (REFS) platform, while Covance will utilize its data assets derived from its extensive clinical and

The 156,000ft² center will expand R&D and manufacturing capabilities for developing various technologies including PCR-based testing, nucleic acid sample preparation, protein purification and antibodies for enzyme-linked immunosorbent assay

The discovery of the second pre-clinical candidate under the collaboration that the companies entered into in 2008 has triggered €1m milestone payment to Ablynx. Ablynx chairman and CEO

The contract funded by NIH is valued up to €60m ($75m) and covers a ten year period. Evotec chief operating officer Dr Mario Polywka said the NIH long

The collaboration will leverage synchrotron X-ray crystallography to design the pharmaceuticals based on the three-dimensional structure of proteins. The research will primarily focus on infectious diseases caused by